CDNA - CareDx Inc logo

CareDx Inc

CDNA

CareDx Inc. develops diagnostic solutions for transplant patients, offering products like AlloSure for monitoring organ health and AlloMap for heart transplants. Its services support outcomes through testing, patient management software, and educational resources.

⚕️ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago →$17,218today

Score Overview

1 Year
Score
Net Growth7x
Net TrendGrew
Net Income Consistency—
Rev Growth20.61%
Rev TrendGrew
Revenue Consistency—
5 Years
Score6.1
Net Growth462.05%
Net Trend40%
Net Income Consistency—
Rev Growth54.55%
Rev Trend80%
Revenue Consistency—
10 Years
Score
Net Growth381.26%
Net Trend50%
Net Income Consistency
Rev Growth11x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth142x
Net Trend42%
Net Income Consistency
Rev Growth16x
Rev Trend92%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where CareDx Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CDNA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-13
$ 65.43—
1 Year2025-10-13
$ 14.53350.31%
5 Years2021-10-13
$ 69.39-5.71%
10 Years2016-10-13
$ 3.8017x
All Time2014-07-17
$ 9.057x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 458M$ 111M$ 373M
2025$ 379M-$ 21M$ 177M
2024$ 333M$ 52M$ 260M
2023$ 280M-$ 190M$ 235M
2022$ 321M-$ 76M$ 293M
2021$ 296M-$ 30M$ 348M
2020$ 192M-$ 18M$ 224M
2019$ 127M-$ 21M$ 38M
2018$ 76M-$ 46M$ 64M
2017$ 48M-$ 55M$ 16M
2016$ 40M-$ 39M$ 17M
2015$ 28M-$ 13M$ 29M
IPO2014$ 27M$ 781K$ 36M
CDNA - CareDx Inc logo

CareDx Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 192M to $ 379M and net income went from -$ 18M to -$ 21M. Revenue increased in 4 of those 5 years; net income in 2.

Across CareDx Inc's full reported history, from 2014 to 2025, revenue grew from $ 27M to $ 379M and net income went from $ 781K to -$ 21M. Revenue increased in 92% of the years measured; net income in 42%.

CareDx Inc currently holds a 5-year HDB Score of 6.1 out of 10. How the HDB Score is calculated.

Membership

Explore CDNA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,125 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies